HTA152 Practical Challenges of Implementing a New Patient-Reported Outcome (PRO) in Oncology Under the German Pharmaceutical Market Restructuring Act (AMNOG) - Results From a Qualitative Focus Group Study
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1610
https://www.valueinhealthjournal.com/article/S1098-3015(22)03815-3/fulltext
Title :
HTA152 Practical Challenges of Implementing a New Patient-Reported Outcome (PRO) in Oncology Under the German Pharmaceutical Market Restructuring Act (AMNOG) - Results From a Qualitative Focus Group Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03815-3&doi=10.1016/j.jval.2022.09.1610
First page :
Section Title :
Open access? :
No
Section Order :
11161